skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: At the time of writing, PRN is up by 10% today. Deeply under water, earnings next week. What to expect? Is it a keeper for the next year or should I sell for tax loss and take my money elsewhere? If a sell, would you wait for earnings? The market is so short term sighted that with COVID PRN might suffer for an extend period of time.
Read Answer Asked by Yves on May 04, 2022
Q: As can be seen from today's NR, we may now be off to the races with OPS. Would appreciate your views.

QUEBEC CITY, April 26, 2022 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced that it has received Health Canada approval for the SavvyWire™, its new guidewire for transcatheter aortic valve replacement procedures, or TAVR.
Read Answer Asked by karl on April 27, 2022
Q: Would appreciate your views on this morning's blockbuster announcement. The SP has been very lethargic over the past year but this could finally move the yardsticks.

CINCINNATI, April 26, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is very pleased to announce the execution of a national insurance contract with a top five health insurer in the United States1.

Management Commentary

“The execution of this national insurance contract with the largest commercial payer in the United States is a major milestone for Quipt and serves as a further accelerant to our ambitious long term growth plans. The national contract is expected to be meaningful as we continue to expand into new states, broadening our operating footprint over a much wider geography. When we make an acquisition, we will be able to immediately leverage the national contract, which is extremely powerful in terms of capturing as many eligible patients as possible,” said Greg Crawford, Chairman and CEO of Quipt. “Moreover, we feel there's still a lot of opportunity for us to go after more national contracts, which would provide the opportunity to add additional payers, and we will continue to work with other large commercial payers to help them better understand our strong patient centric model and the benefits to patients and payors alike. The new national insurance contract, extremely favorable demographics, and our robust operating platform, put us in an industry leading position to provide high touch at home clinical respiratory services throughout the country.”
Read Answer Asked by karl on April 26, 2022
Q: Hello, what is your opinion of OneWater Marine that is dedicated to purchasing and operating top marine retail dealerships across North America ?

It looks like a promising roll up model in a fragmented market.

Thanks
Read Answer Asked by jean on April 25, 2022
Q: This became two questions:
1) I would appreciate hearing your thoughts on Verde's new market study and also your thoughts on the CEO's comments several Brazilian states are competing for their third plant.

2) I'm in a good position that's unexpectedly difficult. I was in early and have very good gains. I've sold a small part just for my own mental comfort. However it really feels like the company is only just starting. Would it make sense to continue with my prior strategy of routinely buying a small position with this company each pay cheque? It's been performing well, I like the CEO, and I continue to really like the story and the path to further growth.
Read Answer Asked by Frederick on April 25, 2022
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!